nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability
|
Suidan, Georgette L. |
|
|
|
9 |
p. 954-963 |
artikel |
2 |
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
|
Awan, Farrukh T. |
|
|
|
9 |
p. 1553-1562 |
artikel |
3 |
Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1–infected cells
|
Ikebe, Emi |
|
|
|
9 |
p. 1845-1858 |
artikel |
4 |
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells
|
Michelozzi, Ilaria M. |
|
|
|
9 |
p. 1725-1738 |
artikel |
5 |
Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy
|
LoCastro, Marissa |
|
|
|
9 |
p. 1871-1884 |
artikel |
6 |
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
|
Gardin, Claude |
|
|
|
9 |
p. 1942-1949 |
artikel |
7 |
Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1
|
Ramassamy, Jill-Léa |
|
|
|
9 |
p. 2044-2048 |
artikel |
8 |
Aiello S, Gastoldi S, Galbusera M, et al. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Blood Adv. 2022;6(3):866-881.
|
|
|
|
|
9 |
p. 2812 |
artikel |
9 |
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity
|
Bloedjes, Timon A. |
|
|
|
9 |
p. 1697-1712 |
artikel |
10 |
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
|
Gouni, Sushanth |
|
|
|
9 |
p. 2757-2762 |
artikel |
11 |
Analysis of MCFD2- and LMAN1-deficient mice demonstrates distinct functions in vivo
|
Zhu, Min |
|
|
|
9 |
p. 1014-1021 |
artikel |
12 |
Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry
|
Kemble, Samuel |
|
|
|
9 |
p. 2932-2946 |
artikel |
13 |
A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD
|
Shi, Qizhen |
|
|
|
9 |
p. 2778-2790 |
artikel |
14 |
A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation
|
Wan, Jun |
|
|
|
9 |
p. 1915-1925 |
artikel |
15 |
Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin
|
Dabas, Rosy |
|
|
|
9 |
p. 1394-1405 |
artikel |
16 |
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
|
Guglielmelli, Paola |
|
|
|
9 |
p. 2927-2931 |
artikel |
17 |
ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint
|
Kekre, Natasha |
|
|
|
9 |
p. 573-576 |
artikel |
18 |
ATG in allogeneic stem cell transplantation: standard of care in 2017? Point
|
Bacigalupo, Andrea |
|
|
|
9 |
p. 569-572 |
artikel |
19 |
A user guide to the American Society of Hematology clinical practice guidelines
|
Izcovich, Ariel |
|
|
|
9 |
p. 2095-2110 |
artikel |
20 |
Bai X, Huang L, Niu L, et al. Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels. Blood Adv. 2016;1(3):219-230.
|
|
|
|
|
9 |
p. 1844 |
artikel |
21 |
Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease
|
Page, Kristin M. |
|
|
|
9 |
p. 2947-2956 |
artikel |
22 |
BK virus–specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation
|
Espada, Eduardo |
|
|
|
9 |
p. 1881-1893 |
artikel |
23 |
Bone marrow transplantation prevents right ventricle disease in the caveolin-1–deficient mouse model of pulmonary hypertension
|
Asosingh, Kewal |
|
|
|
9 |
p. 526-534 |
artikel |
24 |
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
|
Picardi, M. |
|
|
|
9 |
p. 1546-1552 |
artikel |
25 |
Cell-surface C-type lectin-like receptor CLEC-1 dampens dendritic cell activation and downstream Th17 responses
|
Lopez Robles, Maria Dolores |
|
|
|
9 |
p. 557-568 |
artikel |
26 |
Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome
|
Iijima, Mayuko |
|
|
|
9 |
p. 2824-2834 |
artikel |
27 |
Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease
|
Martin de Frémont, Gregoire |
|
|
|
9 |
p. 1682-1691 |
artikel |
28 |
Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function
|
Trory, Justin S. |
|
|
|
9 |
p. 1692-1696 |
artikel |
29 |
Childhood use of antimicrobials and risk of Hodgkin lymphoma: a Danish register–based cohort study
|
Hjalgrim, Henrik |
|
|
|
9 |
p. 1489-1492 |
artikel |
30 |
CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
|
Lucas, Claire M. |
|
|
|
9 |
p. 964-968 |
artikel |
31 |
Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease
|
Srisuwananukorn, Andrew |
|
|
|
9 |
p. 1978-1986 |
artikel |
32 |
Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
|
Patel, Sanjay S. |
|
|
|
9 |
p. 1540-1545 |
artikel |
33 |
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
|
Carreño-Tarragona, Gonzalo |
|
|
|
9 |
p. 1672-1681 |
artikel |
34 |
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
|
Al Malki, Monzr M. |
|
|
|
9 |
p. 2073-2083 |
artikel |
35 |
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
|
Lachowiez, Curtis A. |
|
|
|
9 |
p. 1899-1909 |
artikel |
36 |
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies
|
Müller-Calleja, Nadine |
|
|
|
9 |
p. 979-986 |
artikel |
37 |
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma
|
Bohl, Stephan R. |
|
|
|
9 |
p. 2391-2402 |
artikel |
38 |
Cord blood power and the definition of success after BMT
|
Boelens, Jaap Jan |
|
|
|
9 |
p. 1811-1812 |
artikel |
39 |
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival
|
Martinez, Caridad |
|
|
|
9 |
p. 1823-1830 |
artikel |
40 |
CRISPR-edited megakaryocytes for rapid screening of platelet gene functions
|
Montenont, Emilie |
|
|
|
9 |
p. 2362-2374 |
artikel |
41 |
Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia
|
Izaguirre-Carbonell, Jesus |
|
|
|
9 |
p. 1499-1511 |
artikel |
42 |
Curing CLL: one clone at a time
|
Aslan, Burcu |
|
|
|
9 |
p. 1926-1928 |
artikel |
43 |
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
|
Al Zaki, Ajlan |
|
|
|
9 |
p. 2867-2871 |
artikel |
44 |
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
|
Einarsdottir, Sigrun |
|
|
|
9 |
p. 2723-2730 |
artikel |
45 |
Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis
|
Young, David J. |
|
|
|
9 |
p. 2285-2293 |
artikel |
46 |
Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes
|
Lin, Kimberly |
|
|
|
9 |
p. 2049-2057 |
artikel |
47 |
Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
|
Blondon, Marc |
|
|
|
9 |
p. 2884-2892 |
artikel |
48 |
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease
|
Leonard, Alexis |
|
|
|
9 |
p. 2403-2411 |
artikel |
49 |
Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients
|
Ren, Weicheng |
|
|
|
9 |
p. 2731-2744 |
artikel |
50 |
Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia
|
Wang, Min |
|
|
|
9 |
p. 1416-1428 |
artikel |
51 |
Editorial Board
|
|
|
|
|
9 |
p. i |
artikel |
52 |
Editorial Board
|
|
|
|
|
9 |
p. i |
artikel |
53 |
Editorial Board
|
|
|
|
|
9 |
p. i |
artikel |
54 |
Editorial Board
|
|
|
|
|
9 |
p. i |
artikel |
55 |
Editorial Board
|
|
|
|
|
9 |
p. i |
artikel |
56 |
Editorial Board
|
|
|
|
|
9 |
p. i |
artikel |
57 |
Editorial Board
|
|
|
|
|
9 |
p. i |
artikel |
58 |
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL
|
Strati, Paolo |
|
|
|
9 |
p. 1533-1539 |
artikel |
59 |
Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia
|
Nasimuzzaman, Md |
|
|
|
9 |
p. 1519-1532 |
artikel |
60 |
Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse model
|
Lay, Angelina J. |
|
|
|
9 |
p. 1650-1665 |
artikel |
61 |
Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment
|
Panetti, Silvia |
|
|
|
9 |
p. 1754-1761 |
artikel |
62 |
Fanciullino R, Farnault L, Donnette M, et al. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine. Blood Adv. 2018;2(5):462-469.
|
|
|
|
|
9 |
p. 1013 |
artikel |
63 |
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
|
Pinnix, Chelsea C. |
|
|
|
9 |
p. 1356-1367 |
artikel |
64 |
Front Matter
|
|
|
|
|
9 |
p. ii |
artikel |
65 |
FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice
|
Shrestha, Archana |
|
|
|
9 |
p. 2385-2390 |
artikel |
66 |
Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity
|
Payen, Mathilde |
|
|
|
9 |
p. 1824-1832 |
artikel |
67 |
FVIII half-life extension by coadministration of a D′D3 albumin fusion protein in mice, rabbits, rats, and monkeys
|
Pestel, Sabine |
|
|
|
9 |
p. 1870-1880 |
artikel |
68 |
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death
|
De Smedt, Eva |
|
|
|
9 |
p. 2325-2338 |
artikel |
69 |
Generation of transgenic zebrafish with 2 populations of RFP- and GFP-labeled thrombocytes: analysis of their lipids
|
Fallatah, Weam |
|
|
|
9 |
p. 1406-1415 |
artikel |
70 |
Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
|
Chovanec, Jack |
|
|
|
9 |
p. 1796-1810 |
artikel |
71 |
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML
|
Nguyen, Nam H. K. |
|
|
|
9 |
p. 1769-1783 |
artikel |
72 |
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants
|
Kumar, Anita J. |
|
|
|
9 |
p. 1022-1031 |
artikel |
73 |
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
|
Mehta, Rohtesh S. |
|
|
|
9 |
p. 1441-1449 |
artikel |
74 |
Health following recovery from immune thrombotic thrombocytopenic purpura: the patient’s perspective
|
Kelley, Rachel A. |
|
|
|
9 |
p. 1813-1822 |
artikel |
75 |
Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results
|
Adesina, Oyebimpe O. |
|
|
|
9 |
p. 1476-1488 |
artikel |
76 |
High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis
|
Lombardo, Katharine A. |
|
|
|
9 |
p. 535-544 |
artikel |
77 |
Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly “promising”?
|
Brunner, Andrew M. |
|
|
|
9 |
p. 2854-2866 |
artikel |
78 |
Huang L, Sun X, Yang D, et al. WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. Blood Adv. 2020;4(3):573-585.
|
|
|
|
|
9 |
p. 1916 |
artikel |
79 |
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor–modified T-cell therapy
|
Gonzalez, Michael A. |
|
|
|
9 |
p. 1849-1853 |
artikel |
80 |
Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice
|
Kasztan, Malgorzata |
|
|
|
9 |
p. 1460-1475 |
artikel |
81 |
Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review
|
Bataillard, Edward J. |
|
|
|
9 |
p. 2426-2437 |
artikel |
82 |
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey
|
Harkins, R. Andrew |
|
|
|
9 |
p. 2745-2756 |
artikel |
83 |
Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells
|
Wang, Xiaomei |
|
|
|
9 |
p. 1950-1964 |
artikel |
84 |
Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy
|
Sigurdsson, Valgardur |
|
|
|
9 |
p. 1833-1843 |
artikel |
85 |
Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1
|
Quirino-Teixeira, Anna Cecíllia |
|
|
|
9 |
p. 2018-2031 |
artikel |
86 |
Infused factor VIII–expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A
|
Lyde, Randolph B. |
|
|
|
9 |
p. 1368-1378 |
artikel |
87 |
Kindlin-3 deficiency leads to impaired erythropoiesis and erythrocyte cytoskeleton
|
Szpak, Dorota |
|
|
|
9 |
p. 1739-1753 |
artikel |
88 |
Laboratory monitoring of hemophilia A treatments: new challenges
|
Lenting, Peter J. |
|
|
|
9 |
p. 2111-2118 |
artikel |
89 |
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
|
Clerici, Daniela |
|
|
|
9 |
p. 1621-1634 |
artikel |
90 |
LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα
|
Kohrogi, Kensaku |
|
|
|
9 |
p. 2305-2318 |
artikel |
91 |
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
|
Kennedy, Vanessa E. |
|
|
|
9 |
p. 1713-1724 |
artikel |
92 |
Maternal microchimerism protects hemophilia A patients from inhibitor development
|
Lu, Yeling |
|
|
|
9 |
p. 1867-1869 |
artikel |
93 |
Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match
|
Giri, Jayeeta |
|
|
|
9 |
p. 1987-1997 |
artikel |
94 |
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia
|
Kaeding, Allison J. |
|
|
|
9 |
p. 2350-2361 |
artikel |
95 |
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
|
Wessels, Marja W. |
|
|
|
9 |
p. 2339-2349 |
artikel |
96 |
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
|
Choe, Sung |
|
|
|
9 |
p. 1894-1905 |
artikel |
97 |
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
|
Wise, Jillian F. |
|
|
|
9 |
p. 1859-1866 |
artikel |
98 |
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
|
Hsieh, Matthew M. |
|
|
|
9 |
p. 2058-2063 |
artikel |
99 |
Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML
|
Steinauer, Nickolas |
|
|
|
9 |
p. 1379-1393 |
artikel |
100 |
Neutrophil extracellular traps and inflammasomes cooperatively promote venous thrombosis in mice
|
Campos, Joana |
|
|
|
9 |
p. 2319-2324 |
artikel |
101 |
Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects
|
Rawley, Orla |
|
|
|
9 |
p. 2908-2919 |
artikel |
102 |
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
|
Tomowiak, Cécile |
|
|
|
9 |
p. 2438-2446 |
artikel |
103 |
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
|
Eertink, J.J. |
|
|
|
9 |
p. 2375-2384 |
artikel |
104 |
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones
|
Osman, Afaf E. G. |
|
|
|
9 |
p. 1910-1914 |
artikel |
105 |
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
|
Leppä, Sirpa |
|
|
|
9 |
p. 1906-1915 |
artikel |
106 |
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
|
Jankowski, Wojciech |
|
|
|
9 |
p. 1429-1440 |
artikel |
107 |
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
|
Lee, Je-Hwan |
|
|
|
9 |
p. 2032-2043 |
artikel |
108 |
Phthalides serve as potent modulators to boost fetal hemoglobin induction therapy for β-hemoglobinopathies
|
Chen, Wei-Ren |
|
|
|
9 |
p. 1493-1498 |
artikel |
109 |
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
|
Naeem, Aishath |
|
|
|
9 |
p. 1929-1943 |
artikel |
110 |
Poor tolerability to ponatinib in Indian CML patients
|
Singh, Charanpreet |
|
|
|
9 |
p. 1927-1929 |
artikel |
111 |
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
|
Heuser, Michael |
|
|
|
9 |
p. 2294-2304 |
artikel |
112 |
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia
|
Le, Quy |
|
|
|
9 |
p. 1666-1670 |
artikel |
113 |
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
|
Versluis, Jurjen |
|
|
|
9 |
p. 2835-2846 |
artikel |
114 |
Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura
|
Sun, Lova |
|
|
|
9 |
p. 1512-1518 |
artikel |
115 |
Profilin 1–mediated cytoskeletal rearrangements regulate integrin function in mouse platelets
|
Stritt, Simon |
|
|
|
9 |
p. 1040-1045 |
artikel |
116 |
Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
|
Ceraulo, Antony |
|
|
|
9 |
p. 2773-2777 |
artikel |
117 |
Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma
|
Matsue, Kosei |
|
|
|
9 |
p. 1032-1039 |
artikel |
118 |
Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication
|
Paul, Helmut |
|
|
|
9 |
p. 1831-1848 |
artikel |
119 |
Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease
|
Lee, Margaret T. |
|
|
|
9 |
p. 969-978 |
artikel |
120 |
Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy
|
Humbert, Olivier |
|
|
|
9 |
p. 987-999 |
artikel |
121 |
Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn
|
Aziz-Bose, Rahela |
|
|
|
9 |
p. 2893-2896 |
artikel |
122 |
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL
|
Northend, Michael |
|
|
|
9 |
p. 2920-2926 |
artikel |
123 |
RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea
|
Zouali, Habib |
|
|
|
9 |
p. 2805-2811 |
artikel |
124 |
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
|
Ansell, Stephen M. |
|
|
|
9 |
p. 1917-1926 |
artikel |
125 |
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant
|
Rubinstein, Jeremy D. |
|
|
|
9 |
p. 2897-2907 |
artikel |
126 |
Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198-3225.
|
|
|
|
|
9 |
p. 1671 |
artikel |
127 |
SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD–mutant AML
|
Pacharne, Suruchi |
|
|
|
9 |
p. 2412-2425 |
artikel |
128 |
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT
|
Olsen, Kelly S. |
|
|
|
9 |
p. 1635-1649 |
artikel |
129 |
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
|
Schoettler, Michelle |
|
|
|
9 |
p. 1784-1795 |
artikel |
130 |
Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry
|
Moulis, Guillaume |
|
|
|
9 |
p. 1974-1977 |
artikel |
131 |
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition
|
Maslah, Nabih |
|
|
|
9 |
p. 2813-2823 |
artikel |
132 |
Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD
|
Piper, Clint |
|
|
|
9 |
p. 2791-2804 |
artikel |
133 |
Soluble urokinase-type plasminogen activator receptor in sickle cell disease–associated chronic kidney disease
|
Afangbedji, Nowah |
|
|
|
9 |
p. 1854-1857 |
artikel |
134 |
Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib
|
Morgan, Juliet |
|
|
|
9 |
p. 1450-1459 |
artikel |
135 |
Structure of shear-induced platelet aggregated clot formed in an in vitro arterial thrombosis model
|
Kim, Dongjune A. |
|
|
|
9 |
p. 2872-2883 |
artikel |
136 |
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases
|
Kahn, Justine M. |
|
|
|
9 |
p. 2084-2094 |
artikel |
137 |
Survival following allogeneic transplant in patients with myelofibrosis
|
Gowin, Krisstina |
|
|
|
9 |
p. 1965-1973 |
artikel |
138 |
Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia
|
Imi, Tatsuya |
|
|
|
9 |
p. 1000-1012 |
artikel |
139 |
Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis
|
Felber, Matthias |
|
|
|
9 |
p. 1998-2010 |
artikel |
140 |
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
|
de Botton, Stéphane |
|
|
|
9 |
p. 1858-1870 |
artikel |
141 |
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones
|
Shaw, Lauren C. |
|
|
|
9 |
p. 1885-1898 |
artikel |
142 |
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
|
Assouline, Sarit |
|
|
|
9 |
p. 2011-2017 |
artikel |
143 |
The sialyltransferase ST3Gal-IV guides murine T-cell progenitors to the thymus
|
Sitte, Selina |
|
|
|
9 |
p. 1930-1941 |
artikel |
144 |
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
|
Weinberg, Olga K. |
|
|
|
9 |
p. 2847-2853 |
artikel |
145 |
Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease
|
Qi, Shunan |
|
|
|
9 |
p. 2064-2072 |
artikel |
146 |
Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells
|
Thornton, Sherry |
|
|
|
9 |
p. 545-556 |
artikel |
147 |
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma
|
Charalampous, Charalampos |
|
|
|
9 |
p. 2763-2772 |
artikel |
148 |
Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients
|
Davila, Jennifer |
|
|
|
9 |
p. 1762-1768 |
artikel |